Q3 2017 Holdings
Filed 2017-11-13 | 91 holdings | $160.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $40.7M | 1,577,927 | 25.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $30.8M | 850,000 | 19.2% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $26.1M | 4,975,451 | 16.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $15.4M | 2,746,480 | 9.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $13.9M | 208,000 | 8.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $13.8M | 756,822 | 8.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $11.5M | 509,022 | 7.2% |
| Axogen Inc(AXGN) | COM | 05463X106 | $6.7M | 344,428 | 4.1% |
| Avexis Inc | COM | 05366U100 | $149.7K | 1,547,386 | 0.1% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $112.0K | 729,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $98.9K | 3,153,611 | 0.1% |
| Horizon Pharma PLC | SHS | G4617B105 | $87.7K | 6,917,070 | 0.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $83.4K | 2,527,032 | 0.1% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $69.5K | 1,860,137 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $69.5K | 1,419,911 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $66.9K | $74,100,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $58.5K | 1,365,039 | 0.0% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $48.5K | $45,700,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $45.7K | $75,000,000 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $43.6K | 1,579,285 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $42.7K | 1,525,410 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $41.0K | 1,709,400 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $39.7K | $51,000,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $38.4K | 3,655,494 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $38.2K | $48,000,000 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $37.7K | 1,210,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $36.8K | 362,724 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $35.0K | $40,500,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $32.8K | $27,600,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $30.7K | 632,686 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $28.8K | 824,338 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $28.1K | 2,181,542 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $27.8K | 655,897 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $27.4K | 497,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $27.3K | 1,072,329 | 0.0% |
| Lannet Inc | COM | 516012101 | $26.8K | 1,453,259 | 0.0% |
| K2m Group Hldgs Inc | NOTE 4.125% 8/1 | 48273JAB3 | $24.5K | $20,000,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $23.0K | 615,000 | 0.0% |
| Select MED Hldgs Corp(SEM) | COM | 81619Q105 | $22.9K | 1,194,609 | 0.0% |
| Patterson Companies Inc(PDCOEUR) | COM | 703395103 | $21.9K | 566,000 | 0.0% |
| Fluidigm Corp del | NOTE 2.750% 2/0 | 34385PAA6 | $20.3K | $27,715,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $18.7K | 1,268,945 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $17.7K | 258,000 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $17.4K | 951,629 | 0.0% |
| AAC Hldgs Inc(AACH) | COM | 000307108 | $17.2K | 1,733,276 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $17.1K | 1,901,685 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $16.2K | 850,143 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $16.1K | 298,545 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $16.1K | 672,994 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $15.9K | 945,710 | 0.0% |